How to Deliver PrEP
Use our step-by-step framework for scaling up PrEP.
Explore data and
information on PrEP
across the globe
Tracking Global Approvals
Lenacapavir (LEN) has been reviewed under the “EU Medicines for All” (M4ALL) process and WHO’s Collaborative Registration Procedure (CRP) in order to help national regulators in LMICs accelerate their reviews. This has significantly shortened review time compared to previous PrEP products.
Explore more data:
Long-Acting PrEP Status Update
Faster Rollout for LEN
The timeline for hitting key milestones in product introduction is moving faster for injectable LEN than for any previous PrEP products, starting from the announcement of efficacy results in Phase III trials. LEN’s accelerated timeline compared to oral PrEP, DVR, and CAB reflects a field-wide effort to learn lessons from previous PrEP rollout and not repeat the mistakes of the past.
Explore more data:
PxWire: A Quarterly Update on HIV Prevention
Choice Counselling: A conversation that centres the wants and needs of potential PrEP users
Related Resources and Additional Information
Explore a curated collection of external resources and websites to further your knowledge and access to PrEP-related information. These links provide valuable insights, data, and more.
MOSAIC
Engage
AVAC.ORG
HIV RESOURCE TRACKING
The Long-Acting Therapeutics Patents and Licenses Database
THE GLOBAL PREP TRACKER
MOSAIC Blog
Accelerating introduction of new biomedical prevention products to help individuals, especially women, prevent HIV and other infectious diseases.
Global Connections to Build Capacity
Supporting stakeholders looking to find community, increase their understanding on a topic and implement advocacy action around clinical research and implementation.
Accelerating Product Innovation and Availability
Working to understand potential product users, analyze market data, and convene decision-makers to more effectively design programs that increase access to prevention options.
HIV Prevention Research & Development Investments
The most up-to-date and comprehensive field-wide estimates for HIV prevention and R&D globally.
LAPaL
The first go-to resource for information on long-acting technologies patents and licenses.
Explore trends in PrEP use globally
It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout.